Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

被引：0
|
作者：
Simseki, Cem [1 ]
Wahlin, Staffan [2 ,3 ]
Efe, Cumali [1 ,4 ]
机构：
[1] Hacettepe Univ, Dept Gastroenterol, Ankara, Turkiye
[2] Karolinska Inst, Dept Upper GI Dis, Hepatol Div, Stockholm, Sweden
[3] Karolinska Univ Hosp, Stockholm, Sweden
[4] Harran Univ, Dept Gastroenterol, Sanliurfa, Turkiye
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 81卷 / 01期
关键词：
D O I：
10.1016/j.jhep.2024.02.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e41 / e42
页数：2
相关论文
共 50 条
  • [41] Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy
    Sharzehi, Kaveh
    Huang, Mary Ann
    Schreibman, Ian R.
    Brown, Kimberly A.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 24 (10): : 588 - 592
  • [42] Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy
    Inductivo-Yu, Ira
    Adams, Atoya
    Gish, Robert G.
    Wakil, Adil
    Bzowej, Natalie H.
    Frederick, R. Todd
    Bonacini, Maurizio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (07) : 799 - 802
  • [43] Second-Line Treatment of Autoimmune Hepatitis: Mycophenolate Mofetil as an effective Treatment Option?
    Ploch, P.
    Marquardt, J.
    Fritsche, S.
    Krupp, M.
    Galle, P.
    Teufel, A.
    Barreiros, A.
    INTERNIST, 2013, 54 : 26 - 26
  • [44] Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
    Efe, Cumali
    Al Taii, Haider
    Ytting, Henriette
    Aehling, Niklas
    Bhanji, Rahima A.
    Hagstrom, Hannes
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Muratori, Paolo
    Klintman, Daniel
    Schiano, Thomas D.
    Montano-Loza, Aldo J.
    Berg, Thomas
    Larsen, Fin Stolze
    Alkhouri, Naim
    Ozaslan, Ersan
    Heneghan, Michael A.
    Yoshida, Eric M.
    Wahlin, Staffan
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1348 - 1354
  • [45] Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
    Cumali Efe
    Haider Al Taii
    Henriette Ytting
    Niklas Aehling
    Rahima A. Bhanji
    Hannes Hagström
    Tugrul Purnak
    Luigi Muratori
    Mårten Werner
    Paolo Muratori
    Daniel Klintman
    Thomas D. Schiano
    Aldo J. Montano-Loza
    Thomas Berg
    Fin Stolze Larsen
    Naim Alkhouri
    Ersan Ozaslan
    Michael A. Heneghan
    Eric M. Yoshida
    Staffan Wahlin
    Digestive Diseases and Sciences, 2018, 63 : 1348 - 1354
  • [46] Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes
    Garcia-Buey, L.
    Moreno-Otero, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (06) : 682 - 684
  • [47] Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis
    Moenne-Loccoz, Remy
    Severac, Francois
    Baumert, Thomas F.
    Habersetzer, Francois
    JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 444 - 446
  • [48] Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience
    David C. Wolf
    Lizza Bojito
    Marcelo Facciuto
    Edward Lebovics
    Digestive Diseases and Sciences, 2009, 54 : 2519 - 2522
  • [49] Mycophenolate mofetil in autoimmune hepatitis: Are we ready for primetime?
    Biswas, Sagnik
    Shalimar
    JOURNAL OF HEPATOLOGY, 2024, 81 (04) : e183 - e184
  • [50] Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience
    Wolf, David C.
    Bojito, Lizza
    Facciuto, Marcelo
    Lebovics, Edward
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) : 2519 - 2522
12345